{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:13:11Z","timestamp":1790701991774,"version":"4.1.0"},"reference-count":277,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T00:00:00Z","timestamp":1594252800000},"content-version":"am","delay-in-days":343,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["20417"],"award-info":[{"award-number":["20417"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero Italiano della Salute","doi-asserted-by":"crossref","award":["RF_GR-2011-02351355"],"award-info":[{"award-number":["RF_GR-2011-02351355"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000005","name":"Department of Defense","doi-asserted-by":"publisher","award":["#BC180476P1"],"award-info":[{"award-number":["#BC180476P1"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004802","name":"Breast Cancer Research Program","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004802","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.pharmthera.2019.04.004","type":"journal-article","created":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T20:59:08Z","timestamp":1555361948000},"page":"55-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Stress responses in stromal cells and tumor homeostasis"],"prefix":"10.1016","volume":"200","author":[{"given":"Ilio","family":"Vitale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwenola","family":"Manic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Galassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Galluzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.pharmthera.2019.04.004_bb0005","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cell.2012.04.042","article-title":"A CXCL1 paracrine network links cancer chemoresistance and metastasis","volume":"150","author":"Acharyya","year":"2012","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.04.004_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090907","article-title":"Caffeine mediates sustained inactivation of breast cancer-associated myofibroblasts via up-regulation of tumor suppressor genes","volume":"9","author":"Al-Ansari","year":"2014","journal-title":"PLoS ONE"},{"issue":"78","key":"10.1016\/j.pharmthera.2019.04.004_bb0015","doi-asserted-by":"crossref","first-page":"34681","DOI":"10.18632\/oncotarget.26159","article-title":"ATR suppresses the pro-tumorigenic functions of breast stromal fibroblasts","volume":"9","author":"Al-Ansari","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.pharmthera.2019.04.004_bb0020","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ceb.2016.05.002","article-title":"Stromal dynamic reciprocity in cancer: intricacies of fibroblastic-ECM interactions","volume":"42","author":"Alexander","year":"2016","journal-title":"Current Opinion in Cell Biology"},{"key":"10.1016\/j.pharmthera.2019.04.004_bb0025","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13050","article-title":"Cancer-associated fibroblast-secreted CXCL16 attracts monocytes to promote stroma activation in triple-negative breast cancers","volume":"7","author":"Allaoui","year":"2016","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2019.04.004_bb0030","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-016-2614-5","article-title":"CHEK2 represses breast stromal fibroblasts and their paracrine tumor-promoting effects through suppressing SDF-1 and IL-6","volume":"16","author":"Al-Rakan","year":"2016","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.04.004_bb0035","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1158\/2159-8290.CD-13-0743","article-title":"p38MAPK plays a crucial role in stromal-mediated tumorigenesis","volume":"4","author":"Alspach","year":"2014","journal-title":"Cancer Discovery"},{"issue":"41","key":"10.1016\/j.pharmthera.2019.04.004_bb0040","doi-asserted-by":"crossref","first-page":"14776","DOI":"10.1073\/pnas.1416498111","article-title":"Tissue injury and hypoxia promote malignant progression of prostate cancer by inducing CXCL13 expression in tumor myofibroblasts","volume":"111","author":"Ammirante","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"25","key":"10.1016\/j.pharmthera.2019.04.004_bb0045","doi-asserted-by":"crossref","first-page":"6410","DOI":"10.1073\/pnas.1719076115","article-title":"Altered p53 functionality in cancer-associated fibroblasts contributes to their cancer-supporting features","volume":"115","author":"Arandkar","year":"2018","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.04.004_bb0050","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/ijc.30540","article-title":"Cancer-associated mesenchymal stroma fosters the stemness of osteosarcoma cells in response to intratumoral acidosis via NF-kappaB activation","volume":"140","author":"Avnet","year":"2017","journal-title":"International Journal of Cancer"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.04.004_bb0055","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nri.2017.99","article-title":"The spectrum of T cell metabolism in health and disease","volume":"18","author":"Bantug","year":"2018","journal-title":"Nature Reviews. Immunology"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.04.004_bb0060","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1158\/1078-0432.CCR-12-1800","article-title":"A randomized phase II trial of vismodegib versus placebo with FOLFOX or FOLFIRI and bevacizumab in patients with previously untreated metastatic colorectal cancer","volume":"19","author":"Berlin","year":"2013","journal-title":"Clinical Cancer Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.04.004_bb0065","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cmet.2018.09.012","article-title":"Tumor-Stroma Mechanics Coordinate Amino Acid Availability to Sustain Tumor Growth and Malignancy","volume":"29","author":"Bertero","year":"2019","journal-title":"Cell Metabolism"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.04.004_bb0070","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.cell.2014.09.051","article-title":"Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways","volume":"159","author":"Boelens","year":"2014","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.04.004_bb0075","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1158\/1078-0432.CCR-12-2123","article-title":"Impact of tumor microenvironment and epithelial phenotypes on metabolism in breast cancer","volume":"19","author":"Brauer","year":"2013","journal-title":"Clinical Cancer Research"},{"issue":"7","key":"10.1016\/j.pharmthera.2019.04.004_bb0080","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1158\/1078-0432.CCR-15-2851","article-title":"Fibroblast subtypes regulate responsiveness of luminal breast Cancer to Estrogen","volume":"23","author":"Brechbuhl","year":"2017","journal-title":"Clinical Cancer Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.04.004_bb0085","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/hep.26384","article-title":"Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma","volume":"58","author":"Cadamuro","year":"2013","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.pharmthera.2019.04.004_bb0090","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.4161\/cc.20718","article-title":"Autophagy and senescence in cancer-associated fibroblasts metabolically supports tumor growth and metastasis via glycolysis and ketone production","volume":"11","author":"Capparelli","year":"2012","journal-title":"Cell Cycle"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.04.004_bb0095","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/path.4727","article-title":"Anti-stromal treatment together with chemotherapy targets multiple signalling pathways in pancreatic adenocarcinoma","volume":"239","author":"Carapuca","year":"2016","journal-title":"The Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2019.04.004_bb0100","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15095","article-title":"Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer","volume":"8","author":"Carstens","year":"2017","journal-title":"Nature Communications"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2019.04.004_bb0105","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1093\/carcin\/bgv035","article-title":"The effect of environmental chemicals on the tumor microenvironment","volume":"36","author":"Casey","year":"2015","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.pharmthera.2019.04.004_bb0110","doi-asserted-by":"crossref","first-page":"e887","DOI":"10.1038\/cddis.2013.384","article-title":"Microenvironment mesenchymal cells protect ovarian cancer cell lines from apoptosis by inhibiting XIAP inactivation","volume":"4","author":"Castells","year":"2013","journal-title":"Cell Death & Disease"},{"issue":"36","key":"10.1016\/j.pharmthera.2019.04.004_bb0115","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1200\/JCO.2015.62.8719","article-title":"Randomized Phase Ib\/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer","volume":"33","author":"Catenacci","year":"2015","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.04.004_bb0120","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1038\/s41467-018-05220-6","article-title":"Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer","volume":"9","author":"Cazet","year":"2018","journal-title":"Nature Communications"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.04.004_bb0125","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/onc.2017.319","article-title":"Targeting nuclear receptors in cancer-associated fibroblasts as concurrent therapy to inhibit development of chemoresistant tumors","volume":"37","author":"Chan","year":"2018","journal-title":"Oncogene"},{"issue":"13","key":"10.1016\/j.pharmthera.2019.04.004_bb0130","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1084\/jem.20151665","article-title":"Metronomic chemotherapy prevents therapy-induced stromal activation and induction of tumor-initiating cells","volume":"213","author":"Chan","year":"2016","journal-title":"The Journal of Experimental Medicine"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.04.004_bb0135","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"},{"issue":"20","key":"10.1016\/j.pharmthera.2019.04.004_bb0140","first-page":"E2120","article-title":"Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment","volume":"111","author":"Chaturvedi","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.04.004_bb0145","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1158\/1541-7786.MCR-12-0437-T","article-title":"Metabolic alterations in lung cancer-associated fibroblasts correlated with increased glycolytic metabolism of the tumor","volume":"11","author":"Chaudhri","year":"2013","journal-title":"Molecular Cancer Research"},{"issue":"7","key":"10.1016\/j.pharmthera.2019.04.004_bb0150","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41419-018-0808-2","article-title":"Cisplatin-activated PAI-1 secretion in the cancer-associated fibroblasts with paracrine effects promoting esophageal squamous cell carcinoma progression and causing chemoresistance","volume":"9","author":"Che","year":"2018","journal-title":"Cell Death & Disease"},{"issue":"7637","key":"10.1016\/j.pharmthera.2019.04.004_bb0155","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer-immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.04.004_bb0160","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1038\/s41467-018-06860-4","article-title":"Targeting SPINK1 in the damaged tumour microenvironment alleviates therapeutic resistance","volume":"9","author":"Chen","year":"2018","journal-title":"Nature Communications"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.04.004_bb0165","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1186\/s13058-014-0410-1","article-title":"Cancer\/stroma interplay via cyclooxygenase-2 and indoleamine 2,3-dioxygenase promotes breast cancer progression","volume":"16","author":"Chen","year":"2014","journal-title":"Breast Cancer Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.04.004_bb0170","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","article-title":"Turning foes to friends: targeting cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2019","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.04.004_bb0175","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41419-018-0458-4","article-title":"Cancer-associated fibroblasts induce PDL1+ neutrophils through the IL6-STAT3 pathway that foster immune suppression in hepatocellular carcinoma","volume":"9","author":"Cheng","year":"2018","journal-title":"Cell Death & Disease"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.04.004_bb0180","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.225","article-title":"Human cancer-associated fibroblasts enhance glutathione levels and antagonize drug-induced prostate cancer cell death","volume":"8","author":"Cheteh","year":"2017","journal-title":"Cell Death & Disease"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.04.004_bb0185","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.4049\/jimmunol.1301828","article-title":"IDO-independent suppression of T cell effector function by IFN-gamma-licensed human mesenchymal stromal cells","volume":"192","author":"Chinnadurai","year":"2014","journal-title":"Journal of Immunology"},{"issue":"21","key":"10.1016\/j.pharmthera.2019.04.004_bb0190","doi-asserted-by":"crossref","first-page":"5407","DOI":"10.1158\/1078-0432.CCR-18-0125","article-title":"Cancer-Stimulated CAFs Enhance Monocyte Differentiation and Protumoral TAM Activation via IL6 and GM-CSF Secretion","volume":"24","author":"Cho","year":"2018","journal-title":"Clinical Cancer Research"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.04.004_bb0195","doi-asserted-by":"crossref","first-page":"R78","DOI":"10.1186\/bcr3472","article-title":"Metabolic interaction between cancer cells and stromal cells according to breast cancer molecular subtype","volume":"15","author":"Choi","year":"2013","journal-title":"Breast Cancer Research"},{"key":"10.1016\/j.pharmthera.2019.04.004_bb0200","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12630","article-title":"ATRA mechanically reprograms pancreatic stellate cells to suppress matrix remodelling and inhibit cancer cell invasion","volume":"7","author":"Chronopoulos","year":"2016","journal-title":"Nature Communications"},{"issue":"12","key":"10.1016\/j.pharmthera.2019.04.004_bb0205","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1172\/JCI99159","article-title":"Androgen receptor functions as transcriptional repressor of cancer-associated fibroblast activation","volume":"128","author":"Clocchiatti","year":"2018","journal-title":"The Journal of Clinical Investigation"},{"issue":"31","key":"10.1016\/j.pharmthera.2019.04.004_bb0210","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1038\/onc.2017.65","article-title":"Fibroblasts drive an immunosuppressive and growth-promoting microenvironment in breast cancer via secretion of Chitinase 3-like 1","volume":"36","author":"Cohen","year":"2017","journal-title":"Oncogene"},{"issue":"19","key":"10.1016\/j.pharmthera.2019.04.004_bb0215","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1038\/onc.2013.191","article-title":"Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression","volume":"33","author":"Comito","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.pharmthera.2019.04.004_bb0220","doi-asserted-by":"crossref","DOI":"10.1038\/s41388-019-0688-7","article-title":"Lactate modulates CD4(+) T-cell polarization and induces an immunosuppressive environment, which sustains prostate carcinoma progression via TLR8\/miR21 axis","author":"Comito","year":"2019","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.04.004_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2018.01.011","article-title":"Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer","volume":"33","author":"Costa","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pharmthera.2019.04.004_bb0230","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.semcancer.2013.12.007","article-title":"The role of reactive oxygen species and metabolism on cancer cells and their microenvironment","volume":"25","author":"Costa","year":"2014","journal-title":"Seminars in Cancer Biology"},{"key":"10.1016\/j.pharmthera.2019.04.004_bb0235","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01150","article-title":"Targeting the Epidermal Growth Factor Receptor Can Counteract the Inhibition of Natural Killer Cell Function Exerted by Colorectal Tumor-Associated Fibroblasts","volume":"9","author":"Costa","year":"2018","journal-title":"Frontiers in Immunology"},{"issue":"12","key":"10.1016\/j.pharmthera.2019.04.004_bb0240","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1158\/2326-6066.CIR-18-0098","article-title":"FAP Delineates Heterogeneous and Functionally Divergent Stromal Cells in Immune-Excluded Breast Tumors","volume":"6","author":"Cremasco","year":"2018","journal-title":"Cancer Immunology Research"},{"key":"10.1016\/j.pharmthera.2019.04.004_bb0245","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.freeradbiomed.2018.10.450","article-title":"Cancer-associated fibroblasts modify lung cancer metabolism involving ROS and TGF-beta signaling","volume":"130","author":"Cruz-Bermudez","year":"2019","journal-title":"Free Radical Biology & Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.04.004_bb0250","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cmet.2018.08.007","article-title":"Fibroblasts Mobilize Tumor Cell Glycogen to Promote Proliferation and Metastasis","volume":"29","author":"Curtis","year":"2019","journal-title":"Cell Metabolism"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.04.004_bb0255","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1158\/0008-5472.CAN-17-2320","article-title":"Inactivation of Cancer-Associated-Fibroblasts Disrupts Oncogenic Signaling in Pancreatic Cancer Cells and Promotes Its Regression","volume":"78","author":"Dauer","year":"2018","journal-title":"Cancer Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.04.004_bb0260","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/stem.2509","article-title":"Mesenchymal Stromal Cell Secretion of Programmed Death-1 Ligands Regulates T Cell Mediated Immunosuppression","volume":"35","author":"Davies","year":"2017","journal-title":"Stem Cells"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.04.004_bb0265","doi-asserted-by":"crossref","first-page":"R64","DOI":"10.1186\/bcr3458","article-title":"HIF-1alpha\/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs)","volume":"15","author":"De Francesco","year":"2013","journal-title":"Breast Cancer Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.04.004_bb0270","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13058-017-0923-5","article-title":"GPER mediates the angiocrine actions induced by IGF1 through the HIF-1alpha\/VEGF pathway in the breast tumor microenvironment","volume":"19","author":"De Francesco","year":"2017","journal-title":"Breast Cancer Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.04.004_bb0275","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1084\/jem.20101876","article-title":"Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer","volume":"208","author":"De Monte","year":"2011","journal-title":"The Journal of Experimental Medicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.04.004_bb0280","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1158\/2159-8290.CD-16-0241","article-title":"Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer Relapse","volume":"7","author":"Demaria","year":"2017","journal-title":"Cancer Discovery"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.04.004_bb0285","first-page":"56","article-title":"Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar","volume":"146","author":"Desmouliere","year":"1995","journal-title":"The American Journal of Pathology"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.04.004_bb0290","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/carcin\/bgy006","article-title":"A novel stromal lncRNA signature reprograms fibroblasts to promote the growth of oral squamous cell carcinoma via LncRNA-CAF\/interleukin-33","volume":"39","author":"Ding","year":"2018","journal-title":"Carcinogenesis"},{"issue":"7576","key":"10.1016\/j.pharmthera.2019.04.004_bb0295","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature15548","article-title":"Autophagy mediates degradation of nuclear lamina","volume":"527","author":"Dou","year":"2015","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.pharmthera.2019.04.004_bb0300","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1080\/15384101.2016.1160974","article-title":"The metabolic interaction of cancer cells and fibroblasts - coupling between NAD(P)H and FAD, intracellular pH and hydrogen peroxide","volume":"15","author":"Druzhkova","year":"2016","journal-title":"Cell Cycle"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.04.004_bb0305","doi-asserted-by":"crossref","first-page":"735","DOI":"10.15252\/emmm.201404346","article-title":"Pharmacological targeting of the protein synthesis mTOR\/4E-BP1 pathway in cancer-associated fibroblasts abrogates pancreatic tumour chemoresistance","volume":"7","author":"Duluc","year":"2015","journal-title":"EMBO Molecular Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.04.004_bb0310","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-31658-1","article-title":"Interplay between interferon regulatory factor 1 and BRD4 in the regulation of PD-L1 in pancreatic stellate cells","volume":"8","author":"Ebine","year":"2018","journal-title":"Scientific Reports"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.04.004_bb0315","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1158\/0008-5472.CAN-18-1334","article-title":"Antifibrotic Therapy Disrupts Stromal Barriers and Modulates the Immune Landscape in Pancreatic Ductal Adenocarcinoma","volume":"79","author":"Elahi-Gedwillo","year":"2019","journal-title":"Cancer Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.04.004_bb0320","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1053\/j.gastro.2017.01.010","article-title":"Autophagy Is Required for Activation of Pancreatic Stellate Cells, Associated With Pancreatic Cancer Progression and Promotes Growth of Pancreatic Tumors in Mice","volume":"152","author":"Endo","year":"2017","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.04.004_bb0325","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.bbrc.2013.06.089","article-title":"Cancer associated fibroblasts express pro-inflammatory factors in human breast and ovarian tumors","volume":"437","author":"Erez","year":"2013","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.04.004_bb0330","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ccr.2009.12.041","article-title":"Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner","volume":"17","author":"Erez","year":"2010","journal-title":"Cancer Cell"},{"issue":"50","key":"10.1016\/j.pharmthera.2019.04.004_bb0335","doi-asserted-by":"crossref","first-page":"20212","DOI":"10.1073\/pnas.1320318110","article-title":"Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer","volume":"110","author":"Feig","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"11","key":"10.1016\/j.pharmthera.2019.04.004_bb0340","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.4161\/cc.24902","article-title":"Carbonic anhydrase IX from cancer-associated fibroblasts drives epithelial-mesenchymal transition in prostate carcinoma cells","volume":"12","author":"Fiaschi","year":"2013","journal-title":"Cell Cycle"},{"issue":"19","key":"10.1016\/j.pharmthera.2019.04.004_bb0345","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.1158\/0008-5472.CAN-12-1949","article-title":"Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay","volume":"72","author":"Fiaschi","year":"2012","journal-title":"Cancer Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.04.004_bb0350","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/ncb3094","article-title":"Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis","volume":"17","author":"Fong","year":"2015","journal-title":"Nature Cell Biology"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.04.004_bb0355","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/leu.2015.289","article-title":"Halting pro-survival autophagy by TGFbeta inhibition in bone marrow fibroblasts overcomes bortezomib resistance in multiple myeloma patients","volume":"30","author":"Frassanito","year":"2016","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.04.004_bb0360","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2011.06.047","article-title":"Retinoic acid-induced pancreatic stellate cell quiescence reduces paracrine Wnt-beta-catenin signaling to slow tumor progression","volume":"141","author":"Froeling","year":"2011","journal-title":"Gastroenterology"},{"issue":"13","key":"10.1016\/j.pharmthera.2019.04.004_bb0365","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.15252\/embj.201796697","article-title":"Molecular definitions of autophagy and related processes","volume":"36","author":"Galluzzi","year":"2017","journal-title":"The EMBO Journal"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.04.004_bb0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tcb.2015.11.001","article-title":"Autophagy Mediates Tumor Suppression via Cellular Senescence","volume":"26","author":"Galluzzi","year":"2016","journal-title":"Trends in Cell Biology"},{"issue":"7","key":"10.1016\/j.pharmthera.2019.04.004_bb0375","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nrd.2017.22","article-title":"Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles","volume":"16","author":"Galluzzi","year":"2017","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.04.004_bb0380","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nri.2016.107","article-title":"Immunogenic cell death in cancer and infectious disease","volume":"17","author":"Galluzzi","year":"2017","journal-title":"Nature Reviews. Immunology"},{"issue":"459","key":"10.1016\/j.pharmthera.2019.04.004_bb0385","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat7807","article-title":"The hallmarks of successful anticancer immunotherapy","volume":"10","author":"Galluzzi","year":"2018","journal-title":"Science Translational Medicine"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.04.004_bb0390","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.4161\/cc.11.6.19746","article-title":"Reverse Warburg: straight to cancer","volume":"11","author":"Galluzzi","year":"2012","journal-title":"Cell Cycle"},{"issue":"11","key":"10.1016\/j.pharmthera.2019.04.004_bb0395","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nrd4145","article-title":"Metabolic targets for cancer therapy","volume":"12","author":"Galluzzi","year":"2013","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.04.004_bb0400","doi-asserted-by":"crossref","first-page":"417","DOI":"10.4161\/cc.23275","article-title":"Vitamin B6 metabolism influences the intracellular accumulation of cisplatin","volume":"12","author":"Galluzzi","year":"2013","journal-title":"Cell Cycle"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.04.004_bb0405","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.tcb.2018.08.005","article-title":"WNT Signaling in Cancer Immunosurveillance","volume":"29","author":"Galluzzi","year":"2019","journal-title":"Trends in Cell Biology"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.04.004_bb0410","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/s41418-018-0102-y","article-title":"Oncogene-induced senescence and tumour control in complex biological systems","volume":"25","author":"Galluzzi","year":"2018","journal-title":"Cell Death and Differentiation"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.04.004_bb0415","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","article-title":"Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018","volume":"25","author":"Galluzzi","year":"2018","journal-title":"Cell Death and Differentiation"},{"issue":"11","key":"10.1016\/j.pharmthera.2019.04.004_bb0420","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41580-018-0068-0","article-title":"Linking cellular stress responses to systemic homeostasis","volume":"19","author":"Galluzzi","year":"2018","journal-title":"Nature Reviews. Molecular Cell Biology"},{"issue":"23","key":"10.1016\/j.pharmthera.2019.04.004_bb0425","doi-asserted-by":"crossref","first-page":"7024","DOI":"10.1158\/0008-5472.CAN-14-1346","article-title":"Hedgehog signaling drives radioresistance and stroma-driven tumor repopulation in head and neck squamous cancers","volume":"74","author":"Gan","year":"2014","journal-title":"Cancer Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.04.004_bb0430","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.cyto.2015.09.001","article-title":"Mesenchymal stromal cells derived from cervical cancer tumors induce TGF-beta1 expression and IL-10 expression and secretion in the cervical cancer cells, resulting in protection from cytotoxic T cell activity","volume":"76","author":"Garcia-Rocha","year":"2015","journal-title":"Cytokine"},{"issue":"12","key":"10.1016\/j.pharmthera.2019.04.004_bb0435","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1386829","article-title":"Trial watch: immunogenic cell death induction by anticancer chemotherapeutics","volume":"6","author":"Garg","year":"2017","journal-title":"Oncoimmunology"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.04.004_bb0440","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1053\/j.gastro.2018.05.051","article-title":"NFkappaB in Pancreatic Stellate Cells Reduces Infiltration of Tumors by Cytotoxic T Cells and Killing of Cancer Cells, via Up-regulation of CXCL12","volume":"155","author":"Garg","year":"2018","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.pharmthera.2019.04.004_bb0445","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1101\/gad.279737.116","article-title":"Carcinoma-associated fibroblasts: orchestrating the composition of malignancy","volume":"30","author":"Gascard","year":"2016","journal-title":"Genes & Development"},{"issue":"15","key":"10.1016\/j.pharmthera.2019.04.004_bb0450","doi-asserted-by":"crossref","first-page":"10819","DOI":"10.1074\/jbc.M112.442939","article-title":"Hypoxia-inducible factor 1 (HIF-1) promotes extracellular matrix remodeling under hypoxic conditions by inducing P4HA1, P4HA2, and PLOD2 expression in fibroblasts","volume":"288","author":"Gilkes","year":"2013","journal-title":"The Journal of Biological Chemistry"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.04.004_bb0455","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nrc3726","article-title":"Hypoxia and the extracellular matrix: drivers of tumour metastasis","volume":"14","author":"Gilkes","year":"2014","journal-title":"Nature Reviews. Cancer"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.04.004_bb0460","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/s41467-018-03348-z","article-title":"miR200-regulated CXCL12beta promotes fibroblast heterogeneity and immunosuppression in ovarian cancers","volume":"9","author":"Givel","year":"2018","journal-title":"Nature Communications"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.04.004_bb0465","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41574-018-0096-z","article-title":"The role of hypoxia-inducible factors in metabolic diseases","volume":"15","author":"Gonzalez","year":"2018","journal-title":"Nature Reviews. Endocrinology"},{"key":"10.1016\/j.pharmthera.2019.04.004_bb0470","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2015.00087","article-title":"Cancer-associated fibroblasts from lung tumors maintain their immunosuppressive abilities after high-dose irradiation","volume":"5","author":"Gorchs","year":"2015","journal-title":"Frontiers in Oncology"},{"key":"10.1016\/j.pharmthera.2019.04.004_bb0475","first-page":"1","article-title":"A role for stromal autophagy in cancer-associated fibroblast activation","author":"Goruppi","year":"2019","journal-title":"Autophagy"},{"issue":"12","key":"10.1016\/j.pharmthera.2019.04.004_bb0480","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1016\/j.celrep.2018.08.043","article-title":"Autophagy Controls CSL\/RBPJkappa Stability through a p62\/SQSTM1-Dependent Mechanism","volume":"24","author":"Goruppi","year":"2018","journal-title":"Cell Reports"},{"issue":"10","key":"10.1016\/j.pharmthera.2019.04.004_bb0485","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1016\/j.celrep.2017.08.048","article-title":"The ULK3 Kinase Is Critical for Convergent Control of Cancer-Associated Fibroblast Activation by CSL and GLI","volume":"20","author":"Goruppi","year":"2017","journal-title":"Cell Reports"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.04.004_bb0490","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1438107","article-title":"Gemcitabine alters the proteasome composition and immunopeptidome of tumour cells","volume":"7","author":"Gravett","year":"2018","journal-title":"Oncoimmunology"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.04.004_bb0495","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1158\/1541-7786.MCR-16-0319","article-title":"Stromal Senescence By Prolonged CDK4\/6 Inhibition Potentiates Tumor Growth","volume":"15","author":"Guan","year":"2017","journal-title":"Molecular Cancer Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.04.004_bb0500","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","article-title":"Accessories to the crime: functions of cells recruited to the tumor microenvironment","volume":"21","author":"Hanahan","year":"2012","journal-title":"Cancer Cell"},{"issue":"13","key":"10.1016\/j.pharmthera.2019.04.004_bb0505","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1158\/1078-0432.CCR-13-2972","article-title":"Prevailing role of contact guidance in intrastromal T-cell trapping in human pancreatic cancer","volume":"20","author":"Hartmann","year":"2014","journal-title":"Clinical Cancer Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.04.004_bb0510","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/path.4769","article-title":"Collaboration of cancer-associated fibroblasts and tumour-associated macrophages for neuroblastoma development","volume":"240","author":"Hashimoto","year":"2016","journal-title":"The Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2019.04.004_bb0515","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1748-717X-7-59","article-title":"Cancer-associated fibroblasts from human NSCLC survive ablative doses of radiation but their invasive capacity is reduced","volume":"7","author":"Hellevik","year":"2012","journal-title":"Radiation Oncology"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.04.004_bb0520","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1136\/gutjnl-2016-311954","article-title":"Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancer","volume":"67","author":"Hessmann","year":"2018","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.pharmthera.2019.04.004_bb0525","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1158\/1078-0432.CCR-15-2010","article-title":"Phase Ib Study of PEGylated Recombinant Human Hyaluronidase and Gemcitabine in Patients with Advanced Pancreatic Cancer","volume":"22","author":"Hingorani","year":"2016","journal-title":"Clinical Cancer Research"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.04.004_bb0530","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1200\/JCO.2017.74.9564","article-title":"HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel\/Gemcitabine Versus Nab-Paclitaxel\/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal Adenocarcinoma","volume":"36","author":"Hingorani","year":"2018","journal-title":"Journal of Clinical Oncology"},{"issue":"8","key":"10.1016\/j.pharmthera.2019.04.004_bb0535","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159912","article-title":"Pancreatic Fibroblasts Stimulate the Motility of Pancreatic Cancer Cells through IGF1\/IGF1R Signaling under Hypoxia","volume":"11","author":"Hirakawa","year":"2016","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.04.004_bb0540","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ccell.2015.03.008","article-title":"Intravital imaging reveals how BRAF inhibition generates drug-tolerant microenvironments with high integrin beta1\/FAK signaling","volume":"27","author":"Hirata","year":"2015","journal-title":"Cancer Cell"},{"issue":"14","key":"10.1016\/j.pharmthera.2019.04.004_bb0545","doi-asserted-by":"crossref","first-page":"5770","DOI":"10.1158\/0008-5472.CAN-10-0673","article-title":"Breast carcinoma-associated fibroblasts rarely contain p53 mutations or chromosomal aberrations","volume":"70","author":"Hosein","year":"2010","journal-title":"Cancer Research"},{"issue":"19","key":"10.1016\/j.pharmthera.2019.04.004_bb0550","doi-asserted-by":"crossref","first-page":"27584","DOI":"10.18632\/oncotarget.8488","article-title":"Lung cancer-derived galectin-1 contributes to cancer associated fibroblast-mediated cancer progression and immune suppression through TDO2\/kynurenine axis","volume":"7","author":"Hsu","year":"2016","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.pharmthera.2019.04.004_bb0555","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1016\/j.cellsig.2014.04.015","article-title":"Hexokinase 2 regulates G1\/S checkpoint through CDK2 in cancer-associated fibroblasts","volume":"26","author":"Hu","year":"2014","journal-title":"Cellular Signalling"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.04.004_bb0560","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125625","article-title":"Fibroblast-Derived Exosomes Contribute to Chemoresistance through Priming Cancer Stem Cells in Colorectal Cancer","volume":"10","author":"Hu","year":"2015","journal-title":"PLoS ONE"},{"issue":"10","key":"10.1016\/j.pharmthera.2019.04.004_bb0565","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/cr.2016.109","article-title":"Hepatocellular carcinoma redirects to ketolysis for progression under nutrition deprivation stress","volume":"26","author":"Huang","year":"2016","journal-title":"Cell Research"},{"issue":"16","key":"10.1016\/j.pharmthera.2019.04.004_bb0570","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1158\/1078-0432.CCR-15-2068","article-title":"Regulation of GLI Underlies a Role for BET Bromodomains in Pancreatic Cancer Growth and the Tumor Microenvironment","volume":"22","author":"Huang","year":"2016","journal-title":"Clinical Cancer Research"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.04.004_bb0575","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.18632\/oncotarget.3040","article-title":"DNA damage induces GDNF secretion in the tumor microenvironment with paracrine effects promoting prostate cancer treatment resistance","volume":"6","author":"Huber","year":"2015","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.04.004_bb0580","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055146","article-title":"Arginase II expressed in cancer-associated fibroblasts indicates tissue hypoxia and predicts poor outcome in patients with pancreatic cancer","volume":"8","author":"Ino","year":"2013","journal-title":"PLoS ONE"},{"issue":"23","key":"10.1016\/j.pharmthera.2019.04.004_bb0585","doi-asserted-by":"crossref","first-page":"6851","DOI":"10.1158\/0008-5472.CAN-16-1201","article-title":"Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors","volume":"76","author":"Ireland","year":"2016","journal-title":"Cancer Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.04.004_bb0590","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1136\/gutjnl-2012-302529","article-title":"Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer","volume":"62","author":"Jacobetz","year":"2013","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.04.004_bb0595","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1021\/pr501221g","article-title":"Senescent human fibroblasts show increased glycolysis and redox homeostasis with extracellular metabolomes that overlap with those of irreparable DNA damage, aging, and disease","volume":"14","author":"James","year":"2015","journal-title":"Journal of Proteome Research"},{"issue":"15","key":"10.1016\/j.pharmthera.2019.04.004_bb0600","doi-asserted-by":"crossref","first-page":"20934","DOI":"10.18632\/oncotarget.8064","article-title":"Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects","volume":"7","author":"Jia","year":"2016","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.pharmthera.2019.04.004_bb0605","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00262-017-2003-1","article-title":"Tumor-associated fibrosis as a regulator of tumor immunity and response to immunotherapy","volume":"66","author":"Jiang","year":"2017","journal-title":"Cancer Immunology, Immunotherapy"},{"issue":"8","key":"10.1016\/j.pharmthera.2019.04.004_bb0610","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nm.4123","article-title":"Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy","volume":"22","author":"Jiang","year":"2016","journal-title":"Nature Medicine"},{"issue":"7467","key":"10.1016\/j.pharmthera.2019.04.004_bb0615","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature12626","article-title":"Influence of tumour micro-environment heterogeneity on therapeutic response","volume":"501","author":"Junttila","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2019.04.004_bb0620","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ebiom.2018.12.052","article-title":"Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study","volume":"40","author":"Justice","year":"2019","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.04.004_bb0625","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193178","article-title":"Microenvironmental cues enhance mesenchymal stem cell-mediated immunomodulation and regulatory T-cell expansion","volume":"13","author":"Kadle","year":"2018","journal-title":"PLoS ONE"},{"issue":"9","key":"10.1016\/j.pharmthera.2019.04.004_bb0630","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc.2016.73","article-title":"The biology and function of fibroblasts in cancer","volume":"16","author":"Kalluri","year":"2016","journal-title":"Nature Reviews. Cancer"},{"issue":"17","key":"10.1016\/j.pharmthera.2019.04.004_bb0635","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1158\/0008-5472.CAN-17-2268","article-title":"IL-6 Mediates Cross-Talk between Tumor Cells and Activated Fibroblasts in the Tumor Microenvironment","volume":"78","author":"Karakasheva","year":"2018","journal-title":"Cancer Research"},{"issue":"7637","key":"10.1016\/j.pharmthera.2019.04.004_bb0640","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nature20815","article-title":"Microenvironmental autophagy promotes tumour growth","volume":"541","author":"Katheder","year":"2017","journal-title":"Nature"},{"issue":"19","key":"10.1016\/j.pharmthera.2019.04.004_bb0645","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1158\/1078-0432.CCR-18-0205","article-title":"Cancer-Associated Fibroblasts Affect Intratumoral CD8(+) and FoxP3(+) T Cells Via IL6 in the Tumor Microenvironment","volume":"24","author":"Kato","year":"2018","journal-title":"Clinical Cancer Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.04.004_bb0650","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1158\/2159-8290.CD-18-0193","article-title":"Remodeling of the Collagen Matrix in Aging Skin Promotes Melanoma Metastasis and Affects Immune Cell Motility","volume":"9","author":"Kaur","year":"2019","journal-title":"Cancer Discovery"},{"issue":"23","key":"10.1016\/j.pharmthera.2019.04.004_bb0655","doi-asserted-by":"crossref","first-page":"6509","DOI":"10.1158\/1078-0432.CCR-12-1796","article-title":"A phase II, randomized, placebo-controlled study of vismodegib as maintenance therapy in patients with ovarian cancer in second or third complete remission","volume":"18","author":"Kaye","year":"2012","journal-title":"Clinical Cancer Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.04.004_bb0660","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/stem.2280","article-title":"Adenosinergic Immunosuppression by Human Mesenchymal Stromal Cells Requires Co-Operation with T cells","volume":"34","author":"Kerkela","year":"2016","journal-title":"Stem Cells"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.04.004_bb0665","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192157","article-title":"Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancer","volume":"13","author":"Kilvaer","year":"2018","journal-title":"PLoS ONE"},{"issue":"8","key":"10.1016\/j.pharmthera.2019.04.004_bb0670","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1084\/jem.20170724","article-title":"Convergent roles of ATF3 and CSL in chromatin control of cancer-associated fibroblast activation","volume":"214","author":"Kim","year":"2017","journal-title":"The Journal of Experimental Medicine"},{"issue":"13","key":"10.1016\/j.pharmthera.2019.04.004_bb0675","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1158\/0008-5472.CAN-12-0534","article-title":"Loss of fibroblast HIF-1alpha accelerates tumorigenesis","volume":"72","author":"Kim","year":"2012","journal-title":"Cancer Research"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.04.004_bb0680","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.tcb.2014.11.006","article-title":"Microenvironmental regulation of therapeutic response in cancer","volume":"25","author":"Klemm","year":"2015","journal-title":"Trends in Cell Biology"},{"issue":"12","key":"10.1016\/j.pharmthera.2019.04.004_bb0685","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.4161\/cbt.12.12.18671","article-title":"Glutamine fuels a vicious cycle of autophagy in the tumor stroma and oxidative mitochondrial metabolism in epithelial cancer cells: implications for preventing chemotherapy resistance","volume":"12","author":"Ko","year":"2011","journal-title":"Cancer Biology & Therapy"},{"key":"10.1016\/j.pharmthera.2019.04.004_bb0690","doi-asserted-by":"crossref","DOI":"10.1007\/s10555-018-9740-2","article-title":"Role of prostaglandins in tumor microenvironment","author":"Kobayashi","year":"2018","journal-title":"Cancer Metastasis Reviews"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.04.004_bb0695","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1323617","article-title":"The influence of stromal cells and tumor-microenvironment-derived cytokines and chemokines on CD3(+)CD8(+) tumor infiltrating lymphocyte subpopulations","volume":"6","author":"Koeck","year":"2017","journal-title":"Oncoimmunology"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.04.004_bb0700","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.celrep.2015.07.010","article-title":"The Cancer Cell Oxygen Sensor PHD2 Promotes Metastasis via Activation of Cancer-Associated Fibroblasts","volume":"12","author":"Kuchnio","year":"2015","journal-title":"Cell Reports"},{"issue":"14","key":"10.1016\/j.pharmthera.2019.04.004_bb0705","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.1158\/0008-5472.CAN-17-1076","article-title":"Cancer-Associated Fibroblasts Drive Glycolysis in a Targetable Signaling Loop Implicated in Head and Neck Squamous Cell Carcinoma Progression","volume":"78","author":"Kumar","year":"2018","journal-title":"Cancer Research"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.04.004_bb0710","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ccell.2017.10.005","article-title":"Cancer-Associated Fibroblasts Neutralize the Anti-tumor Effect of CSF1 Receptor Blockade by Inducing PMN-MDSC Infiltration of Tumors","volume":"32","author":"Kumar","year":"2017","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.04.004_bb0715","article-title":"Metabolic reprogramming of stromal fibroblasts by melanoma exosome microRNA favours a pre-metastatic microenvironment","volume":"8","author":"La Shu","year":"2018","journal-title":"Scientific Reports"},{"issue":"420","key":"10.1016\/j.pharmthera.2019.04.004_bb0720","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal3765","article-title":"Targeted apoptosis of myofibroblasts with the BH3 mimetic ABT-263 reverses established fibrosis","volume":"9","author":"Lagares","year":"2017","journal-title":"Science Translational Medicine"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.04.004_bb0725","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/ncb3330","article-title":"The ever-expanding role of HIF in tumour and stromal biology","volume":"18","author":"LaGory","year":"2016","journal-title":"Nature Cell Biology"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.04.004_bb0730","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1038\/s41467-018-03347-0","article-title":"Cancer-associated fibroblasts induce antigen-specific deletion of CD8 (+) T Cells to protect tumour cells","volume":"9","author":"Lakins","year":"2018","journal-title":"Nature Communications"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.04.004_bb0735","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nri3209","article-title":"Multipotent mesenchymal stromal cells and the innate immune system","volume":"12","author":"Le Blanc","year":"2012","journal-title":"Nature Reviews. Immunology"},{"issue":"11","key":"10.1016\/j.pharmthera.2019.04.004_bb0740","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.neo.2016.09.003","article-title":"Tissue Transglutaminase Activates Cancer-Associated Fibroblasts and Contributes to Gemcitabine Resistance in Pancreatic Cancer","volume":"18","author":"Lee","year":"2016","journal-title":"Neoplasia"},{"issue":"30","key":"10.1016\/j.pharmthera.2019.04.004_bb0745","first-page":"E3091","article-title":"Stromal response to Hedgehog signaling restrains pancreatic cancer progression","volume":"111","author":"Lee","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2019.04.004_bb0750","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms9499","article-title":"STAT3-mediated IGF-2 secretion in the tumour microenvironment elicits innate resistance to anti-IGF-1R antibody","volume":"6","author":"Lee","year":"2015","journal-title":"Nature Communications"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.04.004_bb0755","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1172\/JCI95200","article-title":"Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance","volume":"128","author":"Leung","year":"2018","journal-title":"The Journal of Clinical Investigation"},{"issue":"37","key":"10.1016\/j.pharmthera.2019.04.004_bb0760","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1038\/onc.2016.20","article-title":"Extracellular lumican augments cytotoxicity of chemotherapy in pancreatic ductal adenocarcinoma cells via autophagy inhibition","volume":"35","author":"Li","year":"2016","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.pharmthera.2019.04.004_bb0765","doi-asserted-by":"crossref","first-page":"e406","DOI":"10.1038\/emm.2017.255","article-title":"Complex roles of the stroma in the intrinsic resistance to gemcitabine in pancreatic cancer: where we are and where we are going","volume":"49","author":"Liang","year":"2017","journal-title":"Experimental & Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2019.04.004_bb0770","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.biopha.2017.11.024","article-title":"Cancer-associated fi broblasts confer cisplatin resistance of tongue cancer via autophagy activation","volume":"97","author":"Liao","year":"2018","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.04.004_bb0775","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.cmet.2017.09.001","article-title":"ATF4-Induced Metabolic Reprograming Is a Synthetic Vulnerability of the p62-Deficient Tumor Stroma","volume":"26","author":"Linares","year":"2017","journal-title":"Cell Metabolism"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.04.004_bb0780","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ccell.2017.06.009","article-title":"Control of Metastasis by NK Cells","volume":"32","author":"Lopez-Soto","year":"2017","journal-title":"Cancer Cell"},{"issue":"13","key":"10.1016\/j.pharmthera.2019.04.004_bb0785","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1084\/jem.20131195","article-title":"Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A","volume":"210","author":"Lotti","year":"2013","journal-title":"The Journal of Experimental Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.04.004_bb0790","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s12967-016-1057-8","article-title":"Mesenchymal stromal cells derived from cervical cancer produce high amounts of adenosine to suppress cytotoxic T lymphocyte functions","volume":"14","author":"de Lourdes Mora-Garcia","year":"2016","journal-title":"Journal of Translational Medicine"},{"issue":"10","key":"10.1016\/j.pharmthera.2019.04.004_bb0795","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1158\/0008-5472.CAN-12-4601","article-title":"Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a STAT3-dependent manner","volume":"73","author":"Mace","year":"2013","journal-title":"Cancer Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.04.004_bb0800","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/gutjnl-2016-311585","article-title":"IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer","volume":"67","author":"Mace","year":"2018","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.pharmthera.2019.04.004_bb0805","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.15252\/embr.201540107","article-title":"Hypoxia and loss of PHD2 inactivate stromal fibroblasts to decrease tumour stiffness and metastasis","volume":"16","author":"Madsen","year":"2015","journal-title":"EMBO Reports"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.04.004_bb0810","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1136\/gutjnl-2016-312623","article-title":"CHK1-targeted therapy to deplete DNA replication-stressed, p53-deficient, hyperdiploid colorectal cancer stem cells","volume":"67","author":"Manic","year":"2018","journal-title":"Gut"},{"issue":"16","key":"10.1016\/j.pharmthera.2019.04.004_bb0815","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.4161\/cc.25510","article-title":"Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment: RAS and NFkappaB target stromal MCT4","volume":"12","author":"Martinez-Outschoorn","year":"2013","journal-title":"Cell Cycle"},{"key":"10.1016\/j.pharmthera.2019.04.004_bb0820","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.semcancer.2014.01.005","article-title":"Catabolic cancer-associated fibroblasts transfer energy and biomass to anabolic cancer cells, fueling tumor growth","volume":"25","author":"Martinez-Outschoorn","year":"2014","journal-title":"Seminars in Cancer Biology"},{"issue":"22","key":"10.1016\/j.pharmthera.2019.04.004_bb0825","doi-asserted-by":"crossref","first-page":"6495","DOI":"10.1158\/0008-5472.CAN-16-1457","article-title":"Spatial Proximity to Fibroblasts Impacts Molecular Features and Therapeutic Sensitivity of Breast Cancer Cells Influencing Clinical Outcomes","volume":"76","author":"Marusyk","year":"2016","journal-title":"Cancer Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.04.004_bb0830","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150287","article-title":"Cleavage of Type I Collagen by fibroblast activation Protein-alpha Enhances Class A Scavenger Receptor Mediated Macrophage Adhesion","volume":"11","author":"Mazur","year":"2016","journal-title":"PLoS ONE"},{"issue":"13","key":"10.1016\/j.pharmthera.2019.04.004_bb0835","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1080\/15384101.2016.1186317","article-title":"Negative control of CSL gene transcription by stress\/DNA damage response and p53","volume":"15","author":"Menietti","year":"2016","journal-title":"Cell Cycle"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.04.004_bb0840","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1158\/0008-5472.CAN-16-0866","article-title":"Targeting Tumor-Associated Fibroblasts for Therapeutic Delivery in Desmoplastic Tumors","volume":"77","author":"Miao","year":"2017","journal-title":"Cancer Research"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.04.004_bb0845","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.cmet.2017.08.014","article-title":"Exploring Metabolic Configurations of Single Cells within Complex Tissue Microenvironments","volume":"26","author":"Miller","year":"2017","journal-title":"Cell Metabolism"},{"issue":"10","key":"10.1016\/j.pharmthera.2019.04.004_bb0850","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1172\/JCI99397","article-title":"Stromal epigenetic alterations drive metabolic and neuroendocrine prostate cancer reprogramming","volume":"128","author":"Mishra","year":"2018","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2019.04.004_bb0855","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2016.11.010","article-title":"Metabolic hijacking: A survival strategy cancer cells exploit?","volume":"109","author":"Mitchell","year":"2017","journal-title":"Critical Reviews in Oncology\/Hematology"},{"issue":"10","key":"10.1016\/j.pharmthera.2019.04.004_bb0860","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1182\/blood-2016-02-698936","article-title":"PD-L1 expression on neoplastic or stromal cells is respectively a poor or good prognostic factor for adult T-cell leukemia\/lymphoma","volume":"128","author":"Miyoshi","year":"2016","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.pharmthera.2019.04.004_bb0865","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/s41556-018-0131-2","article-title":"Mechanisms and impact of altered tumour mechanics","volume":"20","author":"Mohammadi","year":"2018","journal-title":"Nature Cell Biology"},{"issue":"56","key":"10.1016\/j.pharmthera.2019.04.004_bb0870","doi-asserted-by":"crossref","first-page":"30837","DOI":"10.18632\/oncotarget.25745","article-title":"Chloroquine plays a cell-dependent role in the response to treatment of pancreatic adenocarcinoma","volume":"9","author":"Molejon","year":"2018","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.04.004_bb0875","doi-asserted-by":"crossref","first-page":"R104","DOI":"10.1186\/bcr3224","article-title":"Fibroblast-secreted hepatocyte growth factor mediates epidermal growth factor receptor tyrosine kinase inhibitor resistance in triple-negative breast cancers through paracrine activation of Met","volume":"14","author":"Mueller","year":"2012","journal-title":"Breast Cancer Research"},{"issue":"8","key":"10.1016\/j.pharmthera.2019.04.004_bb0880","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/ijc.23703","article-title":"Role of myofibroblasts in innate chemoresistance of pancreatic carcinoma--epigenetic downregulation of caspases","volume":"123","author":"Muerkoster","year":"2008","journal-title":"International Journal of Cancer"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.04.004_bb0885","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2017.06.031","article-title":"Exosome RNA Unshielding Couples Stromal Activation to Pattern Recognition Receptor Signaling in Cancer","volume":"170","author":"Nabet","year":"2017","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.pharmthera.2019.04.004_bb0890","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1136\/gutjnl-2015-309304","article-title":"Stromal biology and therapy in pancreatic cancer: a changing paradigm","volume":"64","author":"Neesse","year":"2015","journal-title":"Gut"},{"issue":"23","key":"10.1016\/j.pharmthera.2019.04.004_bb0895","doi-asserted-by":"crossref","first-page":"6679","DOI":"10.1158\/0008-5472.CAN-17-1077","article-title":"Secretory Autophagy in Cancer-Associated Fibroblasts Promotes Head and Neck Cancer Progression and Offers a Novel Therapeutic Target","volume":"77","author":"New","year":"2017","journal-title":"Cancer Research"},{"issue":"8","key":"10.1016\/j.pharmthera.2019.04.004_bb0900","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1084\/jem.20140692","article-title":"Fibroblast heterogeneity in the cancer wound","volume":"211","author":"Ohlund","year":"2014","journal-title":"The Journal of Experimental Medicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.04.004_bb0905","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1084\/jem.20162024","article-title":"Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer","volume":"214","author":"Ohlund","year":"2017","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2019.04.004_bb0910","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms16031","article-title":"Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions","volume":"8","author":"Olivares","year":"2017","journal-title":"Nature Communications"},{"issue":"5933","key":"10.1016\/j.pharmthera.2019.04.004_bb0915","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1126\/science.1171362","article-title":"Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer","volume":"324","author":"Olive","year":"2009","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.04.004_bb0920","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ccr.2014.04.005","article-title":"Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival","volume":"25","author":"Ozdemir","year":"2014","journal-title":"Cancer Cell"},{"issue":"23","key":"10.1016\/j.pharmthera.2019.04.004_bb0925","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.4161\/cc.8.23.10238","article-title":"The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma","volume":"8","author":"Pavlides","year":"2009","journal-title":"Cell Cycle"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.04.004_bb0930","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/path.2839","article-title":"Senescent mesenchymal cells accumulate in human fibrosis by a telomere-independent mechanism and ameliorate fibrosis through matrix metalloproteinases","volume":"223","author":"Pitiyage","year":"2011","journal-title":"The Journal of Pathology"},{"issue":"7732","key":"10.1016\/j.pharmthera.2019.04.004_bb0935","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/s41586-018-0697-7","article-title":"Autophagy maintains tumour growth through circulating arginine","volume":"563","author":"Poillet-Perez","year":"2018","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.pharmthera.2019.04.004_bb0940","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/ncb3228","article-title":"Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation","volume":"17","author":"Procopio","year":"2015","journal-title":"Nature Cell Biology"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.04.004_bb0945","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ccr.2012.01.007","article-title":"Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma","volume":"21","author":"Provenzano","year":"2012","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.pharmthera.2019.04.004_bb0950","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/onc.2017.387","article-title":"IL6 derived from cancer-associated fibroblasts promotes chemoresistance via CXCR7 in esophageal squamous cell carcinoma","volume":"37","author":"Qiao","year":"2018","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.04.004_bb0955","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/ng.117","article-title":"No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas","volume":"40","author":"Qiu","year":"2008","journal-title":"Nature Genetics"},{"issue":"11","key":"10.1016\/j.pharmthera.2019.04.004_bb0960","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nature Medicine"},{"issue":"360","key":"10.1016\/j.pharmthera.2019.04.004_bb0965","doi-asserted-by":"crossref","first-page":"360ra135","DOI":"10.1126\/scitranslmed.aaf5219","article-title":"Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases","volume":"8","author":"Rahbari","year":"2016","journal-title":"Science Translational Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.04.004_bb0970","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/stem.2485","article-title":"TLR3 or TLR4 Activation Enhances Mesenchymal Stromal Cell-Mediated Treg Induction via Notch Signaling","volume":"35","author":"Rashedi","year":"2017","journal-title":"Stem Cells"},{"issue":"12","key":"10.1016\/j.pharmthera.2019.04.004_bb0975","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1084\/jem.20180818","article-title":"Bone marrow-derived fibroblasts are a functionally distinct stromal cell population in breast cancer","volume":"215","author":"Raz","year":"2018","journal-title":"The Journal of Experimental Medicine"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.04.004_bb0980","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.stem.2012.08.013","article-title":"CCR2-dependent recruitment of macrophages by tumor-educated mesenchymal stromal cells promotes tumor development and is mimicked by TNFalpha","volume":"11","author":"Ren","year":"2012","journal-title":"Cell Stem Cell"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.04.004_bb0985","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.3892\/or.2015.3779","article-title":"GPER in CAFs regulates hypoxia-driven breast cancer invasion in a CTGF-dependent manner","volume":"33","author":"Ren","year":"2015","journal-title":"Oncology Reports"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.04.004_bb0990","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ccr.2014.04.021","article-title":"Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma","volume":"25","author":"Rhim","year":"2014","journal-title":"Cancer Cell"},{"issue":"13","key":"10.1016\/j.pharmthera.2019.04.004_bb0995","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1038\/onc.2016.353","article-title":"Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells","volume":"36","author":"Richards","year":"2017","journal-title":"Oncogene"},{"issue":"33","key":"10.1016\/j.pharmthera.2019.04.004_bb1000","doi-asserted-by":"crossref","first-page":"22835","DOI":"10.1074\/jbc.M114.563064","article-title":"Platelet-derived growth factor primes cancer-associated fibroblasts for apoptosis","volume":"289","author":"Rizvi","year":"2014","journal-title":"The Journal of Biological Chemistry"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.04.004_bb1005","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1084\/jem.20122344","article-title":"Depletion of stromal cells expressing fibroblast activation protein-alpha from skeletal muscle and bone marrow results in cachexia and anemia","volume":"210","author":"Roberts","year":"2013","journal-title":"The Journal of Experimental Medicine"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.04.004_bb1010","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1158\/1078-0432.CCR-14-2198","article-title":"Molecular pathways: trafficking of metabolic resources in the tumor microenvironment","volume":"21","author":"Romero","year":"2015","journal-title":"Clinical Cancer Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.04.004_bb1015","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/cas.13873","article-title":"Pyruvate secreted from patient-derived cancer-associated fibroblasts supports survival of primary lymphoma cells","volume":"110","author":"Sakamoto","year":"2019","journal-title":"Cancer Science"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.04.004_bb1020","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.scr.2011.04.001","article-title":"Mesenchymal stromal cells up-regulate CD39 and increase adenosine production to suppress activated T-lymphocytes","volume":"7","author":"Saldanha-Araujo","year":"2011","journal-title":"Stem Cell Research"},{"issue":"7","key":"10.1016\/j.pharmthera.2019.04.004_bb1025","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/carcin\/bgr029","article-title":"Activation of autophagy in mesenchymal stem cells provides tumor stromal support","volume":"32","author":"Sanchez","year":"2011","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.pharmthera.2019.04.004_bb1030","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-14-154","article-title":"Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression","volume":"14","author":"Sanita","year":"2014","journal-title":"BMC Cancer"},{"issue":"5-6","key":"10.1016\/j.pharmthera.2019.04.004_bb1035","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201700167","article-title":"Cancer associated fibroblasts: the Architects of Stroma Remodeling","volume":"18","author":"Santi","year":"2018","journal-title":"Proteomics"},{"issue":"52","key":"10.1016\/j.pharmthera.2019.04.004_bb1040","doi-asserted-by":"crossref","first-page":"43234","DOI":"10.1074\/jbc.M112.417303","article-title":"G protein-coupled estrogen receptor mediates the up-regulation of fatty acid synthase induced by 17beta-estradiol in cancer cells and cancer-associated fibroblasts","volume":"287","author":"Santolla","year":"2012","journal-title":"The Journal of Biological Chemistry"},{"issue":"12","key":"10.1016\/j.pharmthera.2019.04.004_bb1045","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1172\/JCI38988","article-title":"Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice","volume":"119","author":"Santos","year":"2009","journal-title":"The Journal of Clinical Investigation"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.04.004_bb1050","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.cell.2014.05.045","article-title":"The reprogramming of tumor stroma by HSF1 is a potent enabler of malignancy","volume":"158","author":"Scherz-Shouval","year":"2014","journal-title":"Cell"},{"issue":"22","key":"10.1016\/j.pharmthera.2019.04.004_bb1055","doi-asserted-by":"crossref","first-page":"5824","DOI":"10.1158\/0008-5472.CAN-12-1201","article-title":"Cancer cells cue the p53 response of cancer-associated fibroblasts to cisplatin","volume":"72","author":"Schmid","year":"2012","journal-title":"Cancer Research"},{"issue":"15","key":"10.1016\/j.pharmthera.2019.04.004_bb1060","doi-asserted-by":"crossref","first-page":"19997","DOI":"10.18632\/oncotarget.7671","article-title":"Fibroblast-induced switching to the mesenchymal-like phenotype and PI3K\/mTOR signaling protects melanoma cells from BRAF inhibitors","volume":"7","author":"Seip","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.04.004_bb1065","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2004.11.022","article-title":"Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase","volume":"7","author":"Selak","year":"2005","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.04.004_bb1070","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.3892\/or.2017.5479","article-title":"Cancer-associated fibroblasts enhance pancreatic cancer cell invasion by remodeling the metabolic conversion mechanism","volume":"37","author":"Shan","year":"2017","journal-title":"Oncology Reports"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.04.004_bb1075","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.7150\/thno.22717","article-title":"Cancer-associated fibroblasts enhance tumor (18)F-FDG uptake and contribute to the intratumor heterogeneity of PET-CT","volume":"8","author":"Shangguan","year":"2018","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.04.004_bb1080","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1084\/jem.20171818","article-title":"Therapeutically targeting tumor microenvironment-mediated drug resistance in estrogen receptor-positive breast cancer","volume":"215","author":"Shee","year":"2018","journal-title":"The Journal of Experimental Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.04.004_bb1085","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cell.2014.08.007","article-title":"Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy","volume":"159","author":"Sherman","year":"2014","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.04.004_bb1090","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1073\/pnas.1620164114","article-title":"Stromal cues regulate the pancreatic cancer epigenome and metabolome","volume":"114","author":"Sherman","year":"2017","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.04.004_bb1095","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrd.2016.193","article-title":"Tumour-associated mesenchymal stem\/stromal cells: emerging therapeutic targets","volume":"16","author":"Shi","year":"2017","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/j.pharmthera.2019.04.004_bb1100","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-8-364","article-title":"Highly variable response to cytotoxic chemotherapy in carcinoma-associated fibroblasts (CAFs) from lung and breast","volume":"8","author":"Sonnenberg","year":"2008","journal-title":"BMC Cancer"},{"issue":"7617","key":"10.1016\/j.pharmthera.2019.04.004_bb1105","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nature19084","article-title":"Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion","volume":"536","author":"Sousa","year":"2016","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.pharmthera.2019.04.004_bb1110","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1158\/0008-5472.CAN-11-1433","article-title":"Hypoxia triggers hedgehog-mediated tumor-stromal interactions in pancreatic cancer","volume":"73","author":"Spivak-Kroizman","year":"2013","journal-title":"Cancer Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.04.004_bb1115","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.ccell.2016.04.014","article-title":"CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma","volume":"29","author":"Steele","year":"2016","journal-title":"Cancer Cell"},{"issue":"7408","key":"10.1016\/j.pharmthera.2019.04.004_bb1120","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nature11183","article-title":"Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion","volume":"487","author":"Straussman","year":"2012","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.04.004_bb1125","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/cdd.2013.149","article-title":"Phylogenetic distinction of iNOS and IDO function in mesenchymal stem cell-mediated immunosuppression in mammalian species","volume":"21","author":"Su","year":"2014","journal-title":"Cell Death and Differentiation"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.04.004_bb1130","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.cell.2018.01.009","article-title":"CD10(+)GPR77(+) Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness","volume":"172","author":"Su","year":"2018","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.pharmthera.2019.04.004_bb1135","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm.2890","article-title":"Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B","volume":"18","author":"Sun","year":"2012","journal-title":"Nature Medicine"},{"issue":"33","key":"10.1016\/j.pharmthera.2019.04.004_bb1140","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1038\/onc.2015.494","article-title":"SFRP2 augments WNT16B signaling to promote therapeutic resistance in the damaged tumor microenvironment","volume":"35","author":"Sun","year":"2016","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.04.004_bb1145","doi-asserted-by":"crossref","first-page":"8633","DOI":"10.18632\/oncotarget.14374","article-title":"Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages","volume":"8","author":"Takahashi","year":"2017","journal-title":"Oncotarget"},{"issue":"26","key":"10.1016\/j.pharmthera.2019.04.004_bb1150","first-page":"E5990","article-title":"Hypoxic tumor microenvironment activates GLI2 via HIF-1alpha and TGF-beta2 to promote chemoresistance in colorectal cancer","volume":"115","author":"Tang","year":"2018","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.04.004_bb1155","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1158\/0008-5472.CAN-17-0524","article-title":"Radiotherapy-Activated Cancer-Associated Fibroblasts Promote Tumor Progression through Paracrine IGF1R Activation","volume":"78","author":"Tommelein","year":"2018","journal-title":"Cancer Research"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.04.004_bb1160","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1158\/1541-7786.MCR-15-0348","article-title":"Chemotherapy-Induced Inflammatory Gene Signature and Protumorigenic Phenotype in Pancreatic CAFs via Stress-Associated MAPK","volume":"14","author":"Toste","year":"2016","journal-title":"Molecular Cancer Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.04.004_bb1165","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1084\/jem.20130110","article-title":"Immune targeting of fibroblast activation protein triggers recognition of multipotent bone marrow stromal cells and cachexia","volume":"210","author":"Tran","year":"2013","journal-title":"The Journal of Experimental Medicine"},{"issue":"11","key":"10.1016\/j.pharmthera.2019.04.004_bb1170","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nri3902","article-title":"Immunological hallmarks of stromal cells in the tumour microenvironment","volume":"15","author":"Turley","year":"2015","journal-title":"Nature Reviews. Immunology"},{"issue":"38","key":"10.1016\/j.pharmthera.2019.04.004_bb1175","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1038\/onc.2017.116","article-title":"Stromal-derived IGF2 promotes colon cancer progression via paracrine and autocrine mechanisms","volume":"36","author":"Unger","year":"2017","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.04.004_bb1180","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ccr.2014.05.004","article-title":"Metabolic reprogramming of stromal fibroblasts through p62-mTORC1 signaling promotes inflammation and tumorigenesis","volume":"26","author":"Valencia","year":"2014","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.04.004_bb1185","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41571-018-0007-1","article-title":"Targeting the tumour stroma to improve cancer therapy","volume":"15","author":"Valkenburg","year":"2018","journal-title":"Nature Reviews. Clinical Oncology"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.04.004_bb1190","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.molcel.2017.04.006","article-title":"DNA Damage in Stem Cells","volume":"66","author":"Vitale","year":"2017","journal-title":"Molecular Cell"},{"key":"10.1016\/j.pharmthera.2019.04.004_bb1195","doi-asserted-by":"crossref","DOI":"10.1016\/j.tcb.2019.01.003","article-title":"Mutational and Antigenic Landscape in Tumor Progression and Cancer Immunotherapy","author":"Vitale","year":"2019","journal-title":"Trends in Cell Biology"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.04.004_bb1200","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1158\/0008-5472.CAN-09-2863","article-title":"Characterization of phosphoglycerate kinase-1 expression of stromal cells derived from tumor microenvironment in prostate cancer progression","volume":"70","author":"Wang","year":"2010","journal-title":"Cancer Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.04.004_bb1205","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1158\/2326-6066.CIR-13-0027","article-title":"Targeting fibroblast activation protein in tumor stroma with chimeric antigen receptor T cells can inhibit tumor growth and augment host immunity without severe toxicity","volume":"2","author":"Wang","year":"2014","journal-title":"Cancer Immunology Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.04.004_bb1210","article-title":"Cancer-associated fibroblasts in a human HEp-2 established laryngeal xenografted tumor are not derived from cancer cells through epithelial-mesenchymal transition, phenotypically activated but karyotypically normal","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS ONE"},{"issue":"10","key":"10.1016\/j.pharmthera.2019.04.004_bb1215","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1080\/15384101.2016.1170269","article-title":"Autophagy protects ovarian cancer-associated fibroblasts against oxidative stress","volume":"15","author":"Wang","year":"2016","journal-title":"Cell Cycle"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.04.004_bb1220","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/1541-7786.MCR-16-0192","article-title":"Senescent Carcinoma-Associated Fibroblasts Upregulate IL8 to Enhance Prometastatic Phenotypes","volume":"15","author":"Wang","year":"2017","journal-title":"Molecular Cancer Research"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.04.004_bb1225","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.cell.2016.04.009","article-title":"Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer","volume":"165","author":"Wang","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2019.04.004_bb1230","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ebiom.2017.02.019","article-title":"Cancer-associated Fibroblasts Promote Irradiated Cancer Cell Recovery Through Autophagy","volume":"17","author":"Wang","year":"2017","journal-title":"EBioMedicine"},{"issue":"8","key":"10.1016\/j.pharmthera.2019.04.004_bb1235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183871","article-title":"Inhibition of ROCK1 kinase modulates both tumor cells and stromal fibroblasts in pancreatic cancer","volume":"12","author":"Whatcott","year":"2017","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.04.004_bb1240","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1053\/j.seminoncol.2017.10.004","article-title":"Metabolic coupling and the Reverse Warburg Effect in cancer: Implications for novel biomarker and anticancer agent development","volume":"44","author":"Wilde","year":"2017","journal-title":"Seminars in Oncology"},{"issue":"7408","key":"10.1016\/j.pharmthera.2019.04.004_bb1245","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nature11249","article-title":"Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors","volume":"487","author":"Wilson","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2019.04.004_bb1250","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.semcdb.2016.11.003","article-title":"Metabolic reprogramming of carcinoma-associated fibroblasts and its impact on metabolic heterogeneity of tumors","volume":"64","author":"Wu","year":"2017","journal-title":"Seminars in Cell & Developmental Biology"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.04.004_bb1255","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1080\/15384101.2016.1253641","article-title":"Cell proliferation downregulated by TGF-beta2-triggered G1\/S checkpoint in clinical CAFs","volume":"16","author":"Wu","year":"2017","journal-title":"Cell Cycle"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.04.004_bb1260","first-page":"687","article-title":"Stromal-epithelial lactate shuttle induced by tumorderived interleukin1beta promotes cell proliferation in oral squamous cell carcinoma","volume":"41","author":"Wu","year":"2018","journal-title":"International Journal of Molecular Medicine"},{"issue":"24","key":"10.1016\/j.pharmthera.2019.04.004_bb1265","doi-asserted-by":"crossref","first-page":"36719","DOI":"10.18632\/oncotarget.9165","article-title":"Soluble factors from stellate cells induce pancreatic cancer cell proliferation via Nrf2-activated metabolic reprogramming and ROS detoxification","volume":"7","author":"Wu","year":"2016","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.04.004_bb1270","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1158\/1535-7163.MCT-17-0927","article-title":"Metformin Suppresses Tumor Progression by Inactivating Stromal Fibroblasts in Ovarian Cancer","volume":"17","author":"Xu","year":"2018","journal-title":"Molecular Cancer Therapeutics"},{"issue":"13","key":"10.1016\/j.pharmthera.2019.04.004_bb1275","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1158\/1078-0432.CCR-11-2972","article-title":"Paracrine receptor activation by microenvironment triggers bypass survival signals and ALK inhibitor resistance in EML4-ALK lung cancer cells","volume":"18","author":"Yamada","year":"2012","journal-title":"Clinical Cancer Research"},{"issue":"38","key":"10.1016\/j.pharmthera.2019.04.004_bb1280","doi-asserted-by":"crossref","first-page":"61469","DOI":"10.18632\/oncotarget.11129","article-title":"Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer","volume":"7","author":"Yamamoto","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.04.004_bb1285","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1172\/JCI93554","article-title":"The fibrotic tumor stroma","volume":"128","author":"Yamauchi","year":"2018","journal-title":"The Journal of Clinical Investigation"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.04.004_bb1290","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41556-018-0083-6","article-title":"Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells","volume":"20","author":"Yan","year":"2018","journal-title":"Nature Cell Biology"},{"issue":"44","key":"10.1016\/j.pharmthera.2019.04.004_bb1295","doi-asserted-by":"crossref","first-page":"16472","DOI":"10.1073\/pnas.0605752103","article-title":"The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis","volume":"103","author":"Yang","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2019.04.004_bb1300","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.leukres.2017.07.002","article-title":"Mesenchymal stem cells derived from multiple myeloma patients protect against chemotherapy through autophagy-dependent activation of NF-kappaB signaling","volume":"60","author":"Yang","year":"2017","journal-title":"Leukemia Research"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.04.004_bb1305","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.cmet.2016.10.011","article-title":"Targeting Stromal Glutamine Synthetase in Tumors Disrupts Tumor Microenvironment-Regulated Cancer Cell Growth","volume":"24","author":"Yang","year":"2016","journal-title":"Cell Metabolism"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.04.004_bb1310","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/1878-0261.12032","article-title":"Chemotherapy induces tumor immune evasion by upregulation of programmed cell death ligand 1 expression in bone marrow stromal cells","volume":"11","author":"Yang","year":"2017","journal-title":"Molecular Oncology"},{"issue":"14","key":"10.1016\/j.pharmthera.2019.04.004_bb1315","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1158\/0008-5472.CAN-15-2973","article-title":"FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3-CCL2 Signaling","volume":"76","author":"Yang","year":"2016","journal-title":"Cancer Research"},{"issue":"48","key":"10.1016\/j.pharmthera.2019.04.004_bb1320","doi-asserted-by":"crossref","first-page":"79617","DOI":"10.18632\/oncotarget.12873","article-title":"miR-31 affects colorectal cancer cells by inhibiting autophagy in cancer-associated fibroblasts","volume":"7","author":"Yang","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.04.004_bb1325","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.stemcr.2013.06.006","article-title":"Multipotent human mesenchymal stromal cells mediate expansion of myeloid-derived suppressor cells via hepatocyte growth factor\/c-met and STAT3","volume":"1","author":"Yen","year":"2013","journal-title":"Stem Cell Reports"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.04.004_bb1330","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1158\/1078-0432.CCR-14-0846","article-title":"Podoplanin-positive cancer-associated fibroblasts in the tumor microenvironment induce primary resistance to EGFR-TKIs in lung adenocarcinoma with EGFR mutation","volume":"21","author":"Yoshida","year":"2015","journal-title":"Clinical Cancer Research"},{"issue":"15","key":"10.1016\/j.pharmthera.2019.04.004_bb1335","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1038\/onc.2016.370","article-title":"Cytoplasmic GPER translocation in cancer-associated fibroblasts mediates cAMP\/PKA\/CREB\/glycolytic axis to confer tumor cells with multidrug resistance","volume":"36","author":"Yu","year":"2017","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.04.004_bb1340","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/cam4.993","article-title":"Cancer-associated fibroblasts promote M2 polarization of macrophages in pancreatic ductal adenocarcinoma","volume":"6","author":"Zhang","year":"2017","journal-title":"Cancer Medicine"},{"issue":"8","key":"10.1016\/j.pharmthera.2019.04.004_bb1345","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.celrep.2015.02.006","article-title":"Metabolic reprogramming of cancer-associated fibroblasts by IDH3alpha downregulation","volume":"10","author":"Zhang","year":"2015","journal-title":"Cell Reports"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.04.004_bb1350","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/ncb2432","article-title":"Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia","volume":"14","author":"Zhang","year":"2012","journal-title":"Nature Cell Biology"},{"key":"10.1016\/j.pharmthera.2019.04.004_bb1355","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2018.00590","article-title":"Blocking Autophagy in Cancer-Associated Fibroblasts Supports Chemotherapy of Pancreatic Cancer Cells","volume":"8","author":"Zhang","year":"2018","journal-title":"Frontiers in Oncology"},{"issue":"12","key":"10.1016\/j.pharmthera.2019.04.004_bb1360","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1158\/2326-6066.CIR-18-0086","article-title":"Stromal Fibroblasts Mediate Anti-PD-1 Resistance via MMP-9 and Dictate TGFbeta Inhibitor Sequencing in Melanoma","volume":"6","author":"Zhao","year":"2018","journal-title":"Cancer Immunology Research"},{"key":"10.1016\/j.pharmthera.2019.04.004_bb1365","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.10250","article-title":"Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism","volume":"5","author":"Zhao","year":"2016","journal-title":"Elife"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.04.004_bb1370","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1158\/0008-5472.CAN-16-1615","article-title":"Long Noncoding RNA LINC00092 Acts in Cancer-Associated Fibroblasts to Drive Glycolysis and Progression of Ovarian Cancer","volume":"77","author":"Zhao","year":"2017","journal-title":"Cancer Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.04.004_bb1375","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/path.4958","article-title":"High-mobility group box 1 released by autophagic cancer-associated fibroblasts maintains the stemness of luminal breast cancer cells","volume":"243","author":"Zhao","year":"2017","journal-title":"The Journal of Pathology"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.04.004_bb1380","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/15384101.2016.1252882","article-title":"Oxidative stress induced autophagy in cancer associated fibroblast enhances proliferation and metabolism of colorectal cancer cells","volume":"16","author":"Zhou","year":"2017","journal-title":"Cell Cycle"},{"issue":"12","key":"10.1016\/j.pharmthera.2019.04.004_bb1385","doi-asserted-by":"crossref","first-page":"19780","DOI":"10.18632\/oncotarget.15540","article-title":"Melanoma-associated fibroblasts decrease tumor cell susceptibility to NK cell-mediated killing through matrix-metalloproteinases secretion","volume":"8","author":"Ziani","year":"2017","journal-title":"Oncotarget"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725819300610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725819300610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:01:26Z","timestamp":1759010486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725819300610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":277,"alternative-id":["S0163725819300610"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2019.04.004","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stress responses in stromal cells and tumor homeostasis","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2019.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}